- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hepatitis C Virus Infection in South Africa
Total 1541 results
-
bioLytical LaboratoriesRecruiting
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
-
Kirby InstituteCompleted
-
Kirby InstituteCompleted
-
Kirby InstituteMerck Sharp & Dohme LLC; The University of New South WalesCompletedChronic Hepatitis C InfectionAustralia
-
Kirby InstituteCompleted
-
bioLytical LaboratoriesRecruitingHepatitis B | Hepatitis B InfectionSouth Africa
-
Kirby InstituteCompletedHepatitis C, ChronicAustralia
-
Gilead SciencesTerminatedHepatitis C Virus InfectionUnited States, United Kingdom, Australia, Germany, Italy, New Zealand, Belgium, Poland, Russian Federation
-
University of Witwatersrand, South AfricaUnknownMeasles | Hepatitis A | VaricellaSouth Africa
-
Kirby InstituteJanssen-Cilag Ltd.CompletedHepatitis C, ChronicAustralia
-
Gilead SciencesTerminatedChronic Hepatitis CUnited States, Australia, Canada, New Zealand
-
Bristol-Myers SquibbWithdrawnChronic Hepatitis CAustralia
-
Kirby InstituteThe University of New South WalesCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionGermany, United States, Australia, United Kingdom, Canada, France, New Zealand
-
Gilead SciencesTerminatedHepatitis C Virus InfectionFrance, Spain, United States, Australia, Canada, Germany, United Kingdom, Italy, New Zealand, Puerto Rico
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
Kirby InstituteCompleted
-
GlaxoSmithKlineCompleted
-
Kirby InstituteBristol-Myers SquibbWithdrawnHepatitis C, ChronicAustralia
-
Janssen Infectious Diseases BVBAVertex Pharmaceuticals IncorporatedCompletedGenotype 1 Chronic Hepatitis C | Treatment NaiveUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Sweden, Brazil, Austria, Ireland, Mexico
-
Janssen Infectious Diseases BVBACompletedHepatitis C Virus InfectionUnited States, Canada
-
Novartis PharmaceuticalsCompletedChronic Hepatitis C Genotype-1 RelapseBelgium, United States, Germany, Spain, Puerto Rico, Taiwan, Australia
-
Janssen Infectious Diseases BVBACompletedHepatitis C Virus InfectionUnited States, Canada
-
Boehringer IngelheimWithdrawnHepatitis C, ChronicAustralia, Spain, Sweden
-
Melbourne HealthHoffmann-La Roche; Monash University; The University of New South Wales; St Vincent... and other collaboratorsCompletedChronic Hepatitis CAustralia
-
Garvan Institute of Medical ResearchCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Italy, United Kingdom, Germany, Belgium, Russian Federation, New Zealand, Australia
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Puerto Rico, New Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Puerto Rico, New Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, New Zealand, Australia, United Kingdom
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, New Zealand, Puerto Rico, Australia
-
Avera McKennan Hospital & University Health CenterWithdrawnChronic Hepatitis CUnited States
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Puerto Rico
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, France, United Kingdom, Germany, Canada, Australia, New Zealand, Puerto Rico
-
Atea Pharmaceuticals, Inc.RecruitingHepatitis C | Hepatitis C, Chronic | HCV | Chronic Hepatitis C Virus | Hepatic CirrhosisTurkey, Brazil, Romania, Canada, Philippines, Pakistan, South Africa, Moldova, Republic of, India, Korea, Republic of, Mauritius
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, France, New Zealand, Canada, Germany, Puerto Rico, United Kingdom, Australia, Italy
-
Bristol-Myers SquibbCompletedHepatitis C Virus InfectionAustralia, France, Germany, Korea, Republic of, Sweden, Taiwan, United Kingdom, United States, Canada, Mexico, Austria, Italy, Spain, Denmark, Argentina, Poland, Ireland, Greece, New Zealand
-
Alios Biopharma Inc.Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicAustralia, New Zealand
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France
-
Kirby InstituteMerck Sharp & Dohme LLCCompletedHepatitis C, ChronicAustralia, Canada, United Kingdom, Belgium, Germany, Norway, Switzerland
-
AbbVieActive, not recruitingHepatitis C Virus (HCV)United States, Australia, Austria, Canada, France, Germany, Italy, Spain
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France, Puerto Rico
-
Bristol-Myers SquibbPharmassetCompletedChronic Hepatitis CUnited States, Puerto Rico
-
Kirby InstituteActive, not recruitingHepatitis C | HIV | HIV-HCV CoinfectionAustralia
-
Bristol-Myers SquibbCompletedHepatitis C VirusAustralia, France, United States, Spain, Italy, Netherlands, Romania, Russian Federation
-
Bristol-Myers SquibbCompletedHepatitis C VirusAustralia, United States, Canada, France, Denmark, Italy
-
AbbVieCompletedChronic Hepatitis C VirusJapan
-
Sanofi Pasteur, a Sanofi CompanyCompletedHepatitis B | Pertussis | Tetanus | Diphtheria | Polio | Human Immunodeficiency Virus InfectionSouth Africa